Subdermal Contraceptive Implants Market Analysis

Product (Etonogestrel Implant, Levonorgestrel Implant)

The etonogestrel implant segment is estimated to hold 66% share of the global subdermal contraceptive implants market during the forecast period. Etonogestrel implant is a hormonal birth control method that comes in the form of a flexible plastic matchstick-sized rod. Additionally, the U.S. Food and Drug Administration has given the etonogestrel subdermal implant approval for contraception for up to three years as a highly effective contraceptive option for women. Moreover, the etonogestrel implant has a failure rate of less than 1%, making it more efficient than female sterilization.

Application (Hospital, Gynecology Clinics, Research Facilities, Women Healthcare Centers)

Subdermal contraceptive implants market from the hospital segment is set to garner a notable share shortly. Subdermal contraceptive implant procedure is usually performed within the hospital premises whereby the gynecologist places the implant in the non-dominant arm, typically, in the consultation room by using a local anesthetic. Besides this, sometimes there may be a need for specialized procedures, including hospital surgery if it gets difficult to remove the implant, or it cannot be found.

Type (Biodegradable, Non-Biodegradable)

Subdermal contraceptive implants market from the biodegradable segment is set to garner significant share by the year 2037. Levonorgestrel (LNG) biodegradable subcutaneous implants have emerged as the most promising long-term contraceptive methods as they release a contraceptive steroid for a predetermined amount of time before dissolving. Besides this, a subdermal biodegradable contraceptive implant is used to provide secure and reliable contraception, as it is a low-cost, biodegradable implant system in the form of a subdermal pellet, is extremely adaptable, and does not need to be surgically removed.

Our in-depth analysis of the global subdermal contraceptive implants market includes the following segments: